Zevalin With Non Myeloablative Allogeneic Stem Cell Transplantation in Patients With Non Hodgkin Lymphoma
Status:
Unknown status
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the ability to combine a radioactive medication
directly targeted against lymphoma cells with the immune effects of an allogeneic blood stem
cell transplant.